Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Special (lipid) delivery: The role of the ionizable lipid pKa in the in vivo delivery of siRNA by lipid nanoparticles has been studied with a large number of head group modifications to the lipids. A tight correlation between the lipid pKa value and silencing of the mouse FVII gene (FVII ED50) was f...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 51; no. 34; pp. 8529 - 8533 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
20.08.2012
WILEY‐VCH Verlag Wiley Wiley Subscription Services, Inc |
Edition | International ed. in English |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Special (lipid) delivery: The role of the ionizable lipid pKa in the in vivo delivery of siRNA by lipid nanoparticles has been studied with a large number of head group modifications to the lipids. A tight correlation between the lipid pKa value and silencing of the mouse FVII gene (FVII ED50) was found, with an optimal pKa range of 6.2–6.5 (see graph). The most potent cationic lipid from this study has ED50 levels around 0.005 mg kg−1 in mice and less than 0.03 mg kg−1 in non‐human primates. |
---|---|
Bibliography: | ark:/67375/WNG-9LHQG0X3-6 Funded Access istex:963AD868E72CE80783D8AAF79B47637FFA842ABB This work was supported in part by the Canadian Institutes for Health Research (CIHR) through U/I grant FRN 59836. We would like to thank John Maraganore for helpful comments. Canadian Institutes for Health Research CIHR - No. FRN 59836 ArticleID:ANIE201203263 Supporting information for this article (experimental details) is available on the WWW under http://dx.doi.org/10.1002/anie.201203263. Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://angewandte.org/open. |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201203263 |